Application of saccharides in preparing medicament for treating platelet quantity related diseases

A technology for platelets and thrombocytopenia, applied in the direction of blood diseases, drug combinations, allergic diseases, etc., can solve the problems that the application of carbohydrate drugs has not been reported, and achieve low cost, wide source of carbohydrates, and strong specificity Effect

Active Publication Date: 2014-03-05
SUZHOU UNIV
View PDF2 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the application of sugar drugs in the treatment o

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of saccharides in preparing medicament for treating platelet quantity related diseases
  • Application of saccharides in preparing medicament for treating platelet quantity related diseases
  • Application of saccharides in preparing medicament for treating platelet quantity related diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0031] The sugars described in the present invention can be prepared according to known conventional methods (Fang Zhijie, edited, "Synthesis and Preparation of Sugar Drugs", first edition, Chemical Industry Press, 2010) or the sugars disclosed in the 1991 invention patent Preparation method Preparation (Patent No.: 91108011, Invention Name: Preparation method of sugars). In addition, the sugars are also commercially available.

[0032] The drug of the present invention may be saccharides alone or a composition containing saccharides.

[0033] In general, drugs are available in various dosage forms, which may be taken orally or injected or applied topically.

[0034] Platelet count-related diseases in the present invention include primary or secondary thrombocytosis, primary or secondary thrombocytopenia, but are not limited to the above-mentioned diseases, and all diseases caused by platelet count are included.

[0035] The inventors found that the combination of the anti-p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an application of saccharides in preparing a medicament for treating platelet quantity related diseases. Saccharides can be one or more of monosaccharides, oxidation-reduction derivatives of the monosaccharides, oligosaccharides, polysaccharides, composite polysaccharides and glycosides. Platelet quantity related diseases comprise primary or secondary thrombocytosis, and primary or secondary thrombocytopenia. Experiments discover that the antibody at an antiplatelet GPIb (glycoprotein Ib) alpha N terminal can induce activation and death of platelets, the platelets can be quickly removed in liver by macrophagocyte, while the saccharides can remarkably inhibit platelet removal caused by the platelet GPIb alpha antibody, and the platelet quantity can be regulated. The application of the saccharides in preparing the medicament for treating platelet quantity related diseases is provided for the first time, and the novel application of the saccharides is expanded.

Description

technical field [0001] The invention relates to the field of biopharmaceuticals, in particular to the application of carbohydrates in the preparation of medicines for treating diseases related to the number of platelets. Background technique [0002] Clinically, abnormal platelet counts caused by various factors can cause related diseases, such as primary or secondary thrombocytosis, primary or secondary thrombocytopenia, including immune thrombocytopenia, etc. Thrombocytosis is a myeloproliferative disorder characterized by abnormal hyperplasia of unknown cause accompanied by persistent increase of platelets. Thrombosis, splenomegaly, and platelet persistence increased significantly, and the etiology was unknown. The bleeding mechanism of this disease may be related to platelet dysfunction or enhanced fibrinolysis. According to the epidemiological survey of essential thrombocythemia in 5 European and American countries, the incidence rate is 0.59 / 100,000 to 2.53 / 100,000, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7008A61K31/7028A61K31/7004A61P7/00A61P7/04A61P37/02
Inventor 戴克胜
Owner SUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap